Gerino Coin (GNC)

The First-Ever Trading Protocol Featuring Zero Loss on Algorithmic Trading

Review Score
ICO Price
0.01 USD
Pre ICO Price
Soft Cap
250000000 USD
Hard Cap
500000000 USD
Start Date
10 January 2023
End Date
10 September 2023

What is Gerino Coin?

GERINO is not a collective investment scheme. Rather it is a platform for investors and cryptocurrency traders who are looking to utilize the most advanced trading tools and technology, as well as the combined wisdom of the community in order to achieve maximum returns in cryptocurrency markets.

GERINO peer -2-peer Asset Platform – the essence and core of the GERINO infrastructure. It implements a successful peer -2-peer business model and disrupts the traditional investment management industry. Investors can easily browse through hundreds of trading Models ( strategies ), provided by cryptocurrency traders and in effect “follow ” the ones matching their goals.

All members can get a clear picture of the current and past performances of each trading Model. By following, the platform does not allocate monies to anyone but rather implements the person’s own decision whereby the platform automatically replicates all trading activity of a chosen Model directly into investors ’ accounts at GERINO, providing a unique peer -2-peer experience along with the safety of funds.

Information displayed on CoinCheckup can be updated by the respective ICOs and/or Crypto representatives and does not present the opinion of and/or the CoinCheckup team.

Trading and investing in digital assets is highly speculative and comes with many risks. The analysis/stats on and it’s subsites are for informational purposes and should not be considered investment advice and or the truth. Statements and financial information on and it’s subsites should not be construed as an endorsement or recommendation to buy, sell or hold.

Please do your own research on all of your investments carefully. Scores are based on averages of third party websites.  Past performance is no indicative of future results. Read the full disclaimer here.